|
Paige Lacatena
Director, Business Development and Licensing, HQ Neurology
Merck & Co.
Philadelphia
USA
|
Paige is currently the S&E Neuroscience Director in Merck’s HQ office and has been with Merck since October 2012. Prior to joining BD&L, she was the Global Director Scientific Affairs for neuroscience and anesthesia, responsible for the Merck Investigator Sponsored Studies Program. In this role she also led the Scientific Leader Input Engagement (SIE) meetings for Merck’s neuroscience and anesthesia programs, supporting the end-to-end pipeline from discovery through lifecycle management by engaging with external experts and key stakeholders. Prior to this role Paige was a member of Merck’s Global Management Acceleration Program where she spent a year as an Associate Director in MSD Finance in Kriens, Switzerland responsible for regional financial planning for corporate BD deals and another year as an Associate Director Global Marketing Neurology for verubecestat, a late stage Alzheimer’s asset. Earlier in her career Paige was an Associate Principal Scientist Biology in the Discovery Neuroscience Department at Merck where she focused on target identification and validation projects. In 2013 and in 2014 Paige was recognized by Forbes magazine as one of the “30 Under 30” in Healthcare and Science.
Paige earned her Ph.D. in neuroscience from Case Western Reserve University and she completed a B.S. in Biology and Biomedical Engineering from Tufts University.
Paige earned her Ph.D. in neuroscience from Case Western Reserve University and she completed a B.S. in Biology and Biomedical Engineering from Tufts University.